3 results match your criteria: "The Ohio State University Wexner Medical Center East Hospital[Affiliation]"

Feasibility Testing of a Nurse-Invented Urinary Drainage Bag Securement Device.

Clin Nurse Spec

December 2024

Author Affiliations: Clinical Nurse Specialist (Ms Meade), Gynecology Oncology & Urology, James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center; Occupational Therapist (Dr Kreuz), OhioHealth; Consulting Research Statistician (Dr Sinnott), Data Coordination and Analysis Center, College of Optometry, The Ohio State University; Clinical Quality and Patient Safety Coordinator (Ms Kuhn), James Cancer Hospital and Solove Research Institute; Clinical Nurse Specialist-Acute Care Nursing (Dr Potts) and Clinical Nurse Specialist-Surgical (Ms Ring), The Ohio State University Wexner Medical Center East Hospital; and Nurse Consultant (Dr Brown), Zenith Healthcare Solutions, Columbus, Ohio.

Purpose/aims: To determine the feasibility of a nurse invention called the Bag Below Bladder (B3) Buddy using validated usability and acceptability tools, in securing urinary drainage bags while patients ambulate.

Design: An intervention study was implemented in a participant dyad consisting of a patient and clinician. Each dyad used the B3 Buddy in 1 encounter, ambulating at least 90 ft in an inpatient unit.

View Article and Find Full Text PDF

The implementation of an automated, pharmacist-driven, scoring system within the EMR has been shown to improve patient care in patients with bacteremia by increasing the adherence to disease specific quality-of-care measures. However, there are a lack of studies evaluating the incorporation of blood culture review into standard, non-antimicrobial stewardship pharmacist workflow. Our institution implemented an automated, pharmacist-driven, antimicrobial scoring system in the electronic medical record (EMR) on August 6, 2019.

View Article and Find Full Text PDF

Previous literature showed an association between hyperthermia and dexmedetomidine (DEX) use for ongoing sedation in non-obese patients. The purpose of this study is to evaluate DEX's effect on temperature in obese critically ill patients. This single center, retrospective, cohort study included patients ≥18 years, admitted to a surgical or medical ICU, received DEX for ≥8 hours as a single continuous infusion sedative, and weighed ≥120% of ideal body weight.

View Article and Find Full Text PDF